INVESTMENT IN MARKETABLE SECURITIES (Tables)

6 Months Ended

Jan. 31, 2021

Investment In Marketable Securities

Schedule of Investment in Marketable Securities

Unrealized gains and losses on these securities are included in operations for the applicable period.

							Change in
							Fair Value
							For the
	Number						Six Months
	of		Fair Value at				Ended
	Shares		July 31, 2020		January 31, 2021		January 31, 2021
Common Shares of Entest Group, Inc. (ENTI)		66,667	$	260	$	593	$	333
Common Shares of Regen Biopharma, Inc. (RGBP)		29,076,665		5,814		29,076		23,262
Series A Preferred Shares of Regen Biopharma, Inc. (RGBPP)		2,907,666		4,362		12,939		8,577
Total			$	10,436	$	42,608	$	32,172